Transmissive spongiform encephalopathies (TSEs) are neurodegenerative diseases characterized by depositions of abnormally folded prion protein (PrPTSE ) in brain. PrPTSE is at present the only specific biochemical marker of human and animal TSEs. Diagnostic tests are based on the detection of PrPres after proteinase K digestion of brain homogenate using Western blot or on the immunohistochemistry of fixed brain tissue, which are both difficult and time consuming. In this work we focused on development of a new type of tests based on PrP detection without need of proteinase K digestion. As deposits of PrPTSE remain in the body for a long time, there is a substantial chance of them being nonenzymatically modified by glycation. The detection of glycated PrPTSE may have a potential to serve as a diagnostic marker. We prepared monoclonal antibodies specific for carboxymethyl lysine/arginine modified prion protein. Bacterially expressed and purified recombinant human prion protein (rhPrP) was modified by glyoxylic acid that introduces carboxymethyl groups on lysine and arginine residues present within the molecule of the protein. Modified rhPrP (rhPrP-CML) was used for immunization of laboratory mice and hybridoma cells were prepared. Screening of cell supernatants resulted in the selection of 4...

Structural investigations on two mycobacterial enzymes were carried out. Tuberculosis still remains a major threat to mankind even though drugs against it have been in use for many decades. The emergence of drug resistant strains of the bacteria calls for the identification of new targets based on which new drugs can be developed to combat the disease. A thorough understanding of the functioning of the target molecules is essential for this approach. We have taken up the structural studies on two such molecules, aspartic proteinases and adenylyl cyclases, of Mycobacterium tuberculosis with a view to obtain insights into their mechanisms of action at the atomic level. The work presented in the thesis includes (i) the identification, cloning, expression, purification and structure determination of a putative aspartic proteinase domain of M. tuberculosis and (ii) the crystal structure of an adenylyl cyclase of M. tuberculosis and its mutant; and also of an adenylyl cyclase from M. avium. Chapter 1 presents an overview of aspartic proteinases and nucleotide cyclases with an emphasis on their structural features. The methods employed during the course of the present work are described in Chapter 2. Work on the putative aspartic proteinase domain identified in M. tuberculosis is presented in Chapter 3. The structure of the aspartic proteinase domain is the first structural report of such domain from any bacteria. A search in the genome of M. tuberculosis showed a weak similarity to the HIV aspartic proteinase sequence. This region corresponds to the C-terminal domain of a PE family protein in M. tuberculosis. The presence of two signature motifs, DTG and DSG, of aspartic proteinases in the full sequence of this domain encouraged us to take up further studies on this domain. Previous reports identifying the protein as a surface antigen and our findings on the occurrence of similar domains in two other PE proteins of M. tuberculosis and also in other pathological strains of Mycobacteria indicated that these domains probably play an important role in infecting the host. The crystal structure of one of the domains showed that it has a pepsin-like fold and the catalytic site architecture of known aspartic proteinases. However, no proteolytic activity was detected. The size of the molecule is intermediate to eukaryotic pepsins and the homodimeric retroviral pepsins. A close examination of the binding site revealed subtle differences when compared to the active enzyme structures. Appropriate mutations of some of the residues in this region to convert it to an active enzyme did not make it active. Once the in vivo function of these putative aspartic proteinase domains is established, their potential to act as drug targets can be probed as the PE proteins are present exclusively in pathogenic Mycobacteria. As part of an ongoing project on adenylyl cyclases of Mycobacteria, we have taken up the structure analysis of the catalytic domains of two adenylyl cyclases; Rv1625c from M. tuberculosis and Ma1120 from M. avium. This work is described in Chapter 4. The wild-type of Rv1625c crystallized as a domain swapped head to head inactive dimer even though it is an active dimer in solution and expected to have a head to tail arrangement as in the previously reported structures of the active forms of the enzyme. Mutation of a phenylalanine residue presumed to occur at the subunit interface of the active dimeric structure of the enzyme to an arginine residue, a conserved residue of guanylyl cyclases, resulted in reduced adenylyl cyclase activity. This mutant crystallized as a monomer though it was expected to be an active dimer. Similarly, Ma1120 also has a monomeric structure in the crystal in spite of showing activity in solution. Though our aim was to capture the active dimers in the crystalline state we did not succeed in this effort in any of the three cases. The catalytic reaction probably takes place very rapidly with the formation of a transient active form of the dimer which cannot be easily crystallized. However, the analysis revealed new structures which are likely to represent the stable states of the enzyme when it is required to stay inactive in certain conditions. We have also established that the N-terminal segments of the enzyme, a loop at the dimeric interface and external factors like pH are involved in determining the oligomeric status of the enzyme thereby regulating its function. Publications 1 Crystal structure of a putative aspartic proteinase domain of the Mycobacterium tuberculosis cell surface antigen PE_PGRS16; Deivanayaga V. Barathy and K. Suguna; FEBS Open Bio (In Press) 2 New structural forms of mycobacterial adenylyl cyclases (in preparation)

Orientador: Prof. Dr. Sergio Daishi Sasaki / Tese (doutorado) - Universidade Federal do ABC, Programa de Pós-Graduação em Biossistemas, São Bernardo do Campo, 2018. / A doença pulmonar obstrutiva crônica é uma doença caracterizada por progressiva limitação do fluxo aéreo e suas principais manifestações são a bronquite crônica e o enfisema pulmonar. O quadro é geralmente irreversível e engloba uma série de processos que incluem a resposta inflamatória anormal dos pulmões com participação ativa de macrófagos, neutrófilos e linfócitos, a falha na reparação de células anormais, a apoptose precoce e a destruição da matriz extracelular ocasionada pelo desequilíbrio entre proteases e antiproteases, sendo esse desequilíbrio apontado como um dos principais mecanismos que levam à instalação da doença. O tabagismo é a principal causa atribuída ao seu aparecimento, seguida por fatores genéticos e ambientais. Algumas enzimas estão relacionadas ao processo de patogênese da DPOC como a elastase de neutrófilos humana e as metaloproteinases 9 e 12. Em trabalhos anteriores o uso do inibidor de serinoproteases rBmTI-A, inibidor do tipo Kunitz-BPTI, resultou na prevenção do enfisema pulmonar por meio do controle da resposta inflamatória comumente observada, além de redução da atividade proteolítica presente no lavado broncoalveolar. Nesse trabalho, o objetivo inicial foi dar prosseguimento à pesquisa com rBmTI-A, com a caracterização da expressão gênica diferencial no modelo de enfisema animal utilizando camundongos, indução realizada com a administração de elastase pancreática porcina (PPE); para isso foi utilizado o ensaio de micro arranjo de DNA (Microarray). Os ensaios de Microarray resultaram na identificação de genes que respondem ao tratamento nos animais induzidos ao enfisema e que receberam o tratamento com rBmTI-A, dentre estes genes estão: genes do sistema imune e inflamação, genes da contração muscular, genes da tradução em mitocôndria e genes de outras funções celulares. Na segunda parte do trabalho, o inibidor de serinoproteases rBmTI-6-D1, inibidor Kunitz-BPTI, foi aplicado no modelo de enfisema pulmonar em camundongos, resultados obtidos previamente já haviam mostrado que rBmTI-6 também apresenta a capacidade de prevenir o desenvolvimento do enfisema induzido por PPE, neste trabalho mostramos que o tratamento utilizando rBmTI-6-D1 evita a perda do recolhimento elástico dos pulmões dos animais induzidos ao enfisema, bem como também evita a degradação alveolar, e o aumento do número de macrófagos e linfócitos nos lavados broncoalveolares dos animais que receberam tratamento em comparação com os que não receberam. Também foi demonstrado que rBmTI-6 evita o aumento de atividade proteolítica (calicreínas e elastase de neutrófilos) no lavado broncoalveolar de animais tratados com o inibidor e induzidos ao enfisema em comparação aos controles. Na terceira parte do trabalho, foram realizados ensaios em cultura de células A549 para investigar o potencial anti-inflamatório dos inibidores rBmTI-A, rBmTI-6-D1 e rBmTI-6-D2/3, a aplicação dos inibidores nestas células mostrou um aparente papel antiinflamatório por meio da diminuição da secreção das citocinas IL-6 e IL-8, no tratamento utilizando rBmTI-6-D1 e rBmTI-6-D2/3. Concluímos que os inibidores rBmTI-A e rBmTI-6 apresentam atividade que previne o desenvolvimento do enfisema induzido por PPE, devido às atividades antiproteases destes inibidores e por interferirem na resposta inflamatória. / Chronic obstructive pulmonary disease is characterized by progressive airflow limitation and its main manifestations are chronic bronchitis and pulmonary emphysema. It is generally irreversible and encompasses a series of processes that include the abnormal inflammatory response of the lungs with active involvement of macrophages, neutrophils and lymphocytes, failure to repair abnormal cells, early apoptosis, and destruction of the extracellular matrix caused by the imbalance between proteases and antiproteases, and this imbalance is one of the main mechanisms that lead to the establishment of the disease. Smoking is the main cause attributed to its onset, followed by genetic and environmental factors. Some enzymes are related to the pathogenesis of COPD such as human neutrophil elastase and metalloproteinases 9 and 12. In previous studies, the use of the serine proteinase inhibitor, rBmTI-A, a Kunitz- BPTI inhibitor type, resulted in the prevention of pulmonary emphysema by controlling of the inflammatory response commonly observed, as well as reducing the proteolytic activity present in bronchoalveolar lavage. In this work, the initial objective was to continue the research with rBmTI-A, with the characterization of differential gene expression in the emphysema model using mice, induced to emphysema by porcine pancreatic elastase (PPE) instillation; to reach this aim a microarray assay was performed. The microarray results in the identification of some genes which are affected by the treatment using rBmTI-A in animals that received PPE instillation previously. Among these genes were identified immune and inflammatory related genes, muscular contraction related genes, translation in mitochondria related genes and genes of other cellular functions. In the second part of this work, the serine proteinase inhibitor rBmTI-6-D1, other Kunitz-BPTI inhibitor type, was applied in the emphysema model using mice; previous results had shown that rBmTI-6 also presented the ability to avoid the emphysema development in the PPE instillation model. The present work we showed that the rBmTI-6-D1 treatment was sufficient to avoid the loss of elastic recoil, an effective decrease in alveolar enlargement and in the number of macrophages and lymphocytes in bronchoalveolar lavage fluid. Proteolytic analysis showed a significant increase in elastase activity in induced emphysema group that is controlled by rBmTI-6-D1. Kallikrein activity was decreased in the induced emphysema and inhibitor treated group when compared to induced emphysema group without treatment. In the third part of this work, assays using A549 cells were performed to investigate the anti-inflammatory potential of rBmTI-A, rBmTI- 6-D1 and rBmTI-6-D2/3 inhibitors. These inhibitors presented an apparent antiinflammatory role, due the reduced levels of IL-6 and IL-8 that were secreted by A549 cell when treated with rBmTI-6-D1 and rBmTI-6-D2/3. We concluded that rBmTI-A and rBmTI-6 inhibitors prevent the emphysema development induced by PPE, due the anti-proteinases activities of these inhibitors and by its interference in inflammatory response.

Transmissive spongiform encephalopathies (TSEs) are neurodegenerative diseases characterized by depositions of abnormally folded prion protein (PrPTSE ) in brain. PrPTSE is at present the only specific biochemical marker of human and animal TSEs. Diagnostic tests are based on the detection of PrPres after proteinase K digestion of brain homogenate using Western blot or on the immunohistochemistry of fixed brain tissue, which are both difficult and time consuming. In this work we focused on development of a new type of tests based on PrP detection without need of proteinase K digestion. As deposits of PrPTSE remain in the body for a long time, there is a substantial chance of them being nonenzymatically modified by glycation. The detection of glycated PrPTSE may have a potential to serve as a diagnostic marker. We prepared monoclonal antibodies specific for carboxymethyl lysine/arginine modified prion protein. Bacterially expressed and purified recombinant human prion protein (rhPrP) was modified by glyoxylic acid that introduces carboxymethyl groups on lysine and arginine residues present within the molecule of the protein. Modified rhPrP (rhPrP-CML) was used for immunization of laboratory mice and hybridoma cells were prepared. Screening of cell supernatants resulted in the selection of 4...

The nuclear lamina protein, lamin A is produced by proteolytic cleavage of a 74 kDa precursor protein, prelamin A. The conversion of this precursor to mature lamin A is mediated by a specific endoprotease, prelamin A endoprotease. Subnuclear fractionation indicates that the prelamin A endoprotease is localized at the nuclear membrane. The enzyme appears to be an integral membrane protein, as it can only be removed from the nuclear envelope with detergent. It is effectively solubilized by the detergent n-octyl-beta-D-glucopyranoside and can be partially-purified (approximately 1200-fold) by size exclusion and cation exchange (Mono S) chromatography. Prelamin A endoprotease from HeLa cells was eluted from Mono S with 0.3 M sodium chloride as a single peak of activity. SDS-PAGE analysis of this prelamin A endoprotease preparation shows that it contains one major polypeptide at 65 kDa and smaller amounts of a second 68 kDa polypeptide. Inhibition of the enzyme activity in this preparation by specific serine protease inhibitors is consistent with the enzyme being a serine protease.

La caractérisation de nanomatériaux dans des matrices alimentaires et animales suscite un intérêt scientifique important afin d’évaluer les risques potentiels de l’exposition liés à l’utilisation grandissante des nanomatériaux par plusieurs industries, y compris un certain nombre d’applications agroalimentaires. Un facteur limitant à l’étude et la réglementation des nanomatériaux dans des matrices complexes telle que la nourriture est l’absence de méthodes standardisées pour l’extraction et l’analyse de nanoparticules, tout en évitant l’altération de certaines caractéristiques physicochimiques des nanoparticules. Les travaux présentés dans ce mémoire abordent l’optimisation de plusieurs approches de préparation d’échantillon (hydrolyse enzymatique et alcaline) pour l’extraction de nanoparticules d’Ag préalablement équilibrées dans une matrice de boeuf haché mi-maigre. Les nanoparticules extraites ont été analysées par spectrométrie de masse à plasma à couplage inductif en mode particule unique (SP-ICP-MS) permettant la mesure de leur taille et concentration, mais aussi de la concentration en métal dissous, le tout à de très faibles concentrations (de l’ordre du ng/L). La validation de l’analyse par SP-ICP-MS a été réalisée par évaluation de la répétabilité, de la détermination des limites de détection et par une investigation de l’influence du traitement de données sur l’interprétation des résultats. Les pertes de nanoparticules lors de la préparation des échantillons ont été minimisées par l’identification et l’optimisation de paramètres clés tels que la composition du médium d’extraction, l’utilisation d’ultrasons et de la manipulation de l’échantillon après dégradation de la matrice. Les meilleurs recouvrements ont été obtenus par hydrolyse alcaline de la matrice en utilisant de l’hydroxyde de tetramethylammonium (TMAH), mais les échantillons obtenus étaient moins stables et plus susceptibles aux altérations des propriétés physicochimiques des nanoparticules que pour la dégradation par hydrolyse enzymatique utilisant lipase et pancréatine de porc. / The regulation and characterization of nanomaterials in foods and animal matrices are of great interest due to the potential risks associated with their exposure and the increasing number of instances where they are used within the food industry. One factor limiting the scientifically rigorous regulation of nanoparticles in foods is the lack of standardized procedures for the extraction of nanoparticles (NP) from complex matrices, without alteration of their physico-chemical properties. To this end, two sample preparation approaches (enzymatic- and alkaline-based hydrolyses) were tested and optimized in order to extract 40 nm Ag NP, following their equilibration with a fatty ground beef matrix. Extracted NP were characterized using single particle inductively coupled plasma mass spectrometry (SP-ICP-MS), allowing the determination of NP size and concentrations and also dissolved metal concentrations at trace levels. Validation of the SP-ICP-MS analysis was achieved by an evaluation of the repeatability and accuracy and by a determination of the various detection limits. Finally, we also looked into the influence of data treatment on interpretation of the results. NP losses during the sample preparation were minimized by identifying and optimizing key parameters such as the composition of the extraction media, usage of ultrasonication or the handling of the sample after separation from the undigested matter, among other points. The alkaline approach using TMAH (tetramethylammonium hydroxide) was found to have the highest recoveries, however processed samples were found to be less stable and more prone to alteration of the Ag NP physicochemical characteristics than samples processed using an enzymatic digestion based upon pork pancreatin and lipase.

Proteins and their intricate network of interactions are fundamental to many molecular processes that govern life. Mass spectrometry-based structural proteomics represents a powerful set of techniques for characterizing protein structures and interactions. The last decade has witnessed a large-scale adoption in the application of these techniques toward solving a variety of biological questions. Addressing these questions has often been coincident with the further development of these techniques. Insight into the structures of individual proteins and their interactions with other proteins in a proteome-wide context has been made possible by recent developments in the relatively new field of chemical crosslinking combined with mass spectrometry. In these experiments crosslinking reagents are used to capture protein-protein interactions by forming covalent linkages between proximal amino acid residues. The crosslinked proteins are then enzymatically digested into peptides, and the covalently-coupled crosslinked peptides are identified by mass spectrometry. These identified crosslinked peptides thus provide evidence of interacting regions within or between proteins. In this dissertation the development of tools and methods that facilitate this powerful technique are described. The primary arc of this work follows the development and application of mass spectrometry-based approaches for the identification of protein crosslinks ranging from those which exist endogenously to those which are introduced synthetically. Firstly, the development of a novel strategy for comprehensive determination of naturally occurring protein crosslinks in the form of disulfide bonds is described. Secondly, the application of crosslinking reagents to create synthetic crosslinks in proteins coupled with molecular dynamics simulations is explored in order to structurally characterize the intrinsically disordered tau protein. Thirdly, improvements to a crosslinking-mass spectrometry method for defining a protein-protein interactome in a complex sample is developed. Altogether, these described approaches represent a toolset to allow researchers to access information about protein structure and interactions. / Graduate

Die rheumatoide Arthritis ist eine chronisch-entzündliche Bindegewebserkrankung mit symmetrischem Befall der Gelenke. Die genaue Ätiologie ist bisher unbekannt. Aktivierte synoviale Fibroblasten sollen durch gesteigerte Adhäsion und Produktion von proinflammatorischen Zytokinen und Matrix-lysierenden Proteasen maßgeblich an der Gelenkdestruktion beteiligt sein. Ziel dieser Arbeit war es, ein neues in-vivo-Knorpeldestruktions-Modell zu etablieren, in welchem unter immunkompetenten Bedingungen, die Invasion und Destruktion von Gelenkknorpel durch die Fibroblasten-Zelllinie LS48 über einen längeren Zeitraum simuliert werden kann. Die am Institut für klinische Immunologie der Medizinischen Fakultät der Universität Leipzig etablierte Zelllinie LS48 wurde in die ipsilateralen Kniegelenke von BALB/c-Mäusen injiziert. Die dadurch induzierte Gewebsdestruktion wurde über zehn Wochen in zweiwöchigem Abstand histopathologisch beurteilt und klassifiziert. Als vergleichende Fibroblasten-Zelllinie wurden nicht-invasive NIH/3T3-Zellen eingesetzt. An Hand der Score-Parameter Zellinvasion, Pannusformation und Knorpeldestruktion wurde eine mäßige bis schwer-wiegende Gewebsdestruktion durch die LS48-Zellen bereits ab der zweiten Untersuchungswoche lichtmikroskopisch nachgewiesen, ohne dass dabei pathologische Effekte in den kontralateralen Kniegelenken aufgetreten sind. Polarisationsmikroskopisch wurden für den Parameter Knorpeldestruktion vergleichbare Ergebnisse erzielt. Damit wurde gezeigt, dass das Modell BALB/c LS48 ein erfolgversprechendes Instrument darstellt, das zur Testung neuer therapeutischer Strategien gegen die Gelenkdestruktion verwendet werden kann. Inwieweit die Auseinandersetzung der LS48-Zellen mit dem spezifischen Immunsystem der BALB/c-Maus Auswirkungen auf den Verlauf der Gewebsdestruktion hat, sollte in weiterführenden Experimenten untersucht werden.

Die rheumatoide Arthritis ist eine chronisch-entzündliche Bindegewebserkrankung mit symmetrischem Befall der Gelenke. Die genaue Ätiologie ist bisher unbekannt. Aktivierte synoviale Fibroblasten sollen durch gesteigerte Adhäsion und Produktion von proinflammatorischen Zytokinen und Matrix-lysierenden Proteasen maßgeblich an der Gelenkdestruktion beteiligt sein. Ziel dieser Arbeit war es, ein neues in-vivo-Knorpeldestruktions-Modell zu etablieren, in welchem unter immunkompetenten Bedingungen, die Invasion und Destruktion von Gelenkknorpel durch die Fibroblasten-Zelllinie LS48 über einen längeren Zeitraum simuliert werden kann. Die am Institut für klinische Immunologie der Medizinischen Fakultät der Universität Leipzig etablierte Zelllinie LS48 wurde in die ipsilateralen Kniegelenke von BALB/c-Mäusen injiziert. Die dadurch induzierte Gewebsdestruktion wurde über zehn Wochen in zweiwöchigem Abstand histopathologisch beurteilt und klassifiziert. Als vergleichende Fibroblasten-Zelllinie wurden nicht-invasive NIH/3T3-Zellen eingesetzt. An Hand der Score-Parameter Zellinvasion, Pannusformation und Knorpeldestruktion wurde eine mäßige bis schwer-wiegende Gewebsdestruktion durch die LS48-Zellen bereits ab der zweiten Untersuchungswoche lichtmikroskopisch nachgewiesen, ohne dass dabei pathologische Effekte in den kontralateralen Kniegelenken aufgetreten sind. Polarisationsmikroskopisch wurden für den Parameter Knorpeldestruktion vergleichbare Ergebnisse erzielt. Damit wurde gezeigt, dass das Modell BALB/c LS48 ein erfolgversprechendes Instrument darstellt, das zur Testung neuer therapeutischer Strategien gegen die Gelenkdestruktion verwendet werden kann. Inwieweit die Auseinandersetzung der LS48-Zellen mit dem spezifischen Immunsystem der BALB/c-Maus Auswirkungen auf den Verlauf der Gewebsdestruktion hat, sollte in weiterführenden Experimenten untersucht werden.:Bibliographische Zusammenfassung II Inhaltsverzeichnis III Abkürzungsverzeichnis IV 1 Einleitung 1 1.1 Rheumatische Erkrankungen 1 1.2 Die rheumatoide Arthritis 2 1.2.1 Immunologische Grundlagen der rheumatoiden Arthritis 2 1.2.1.1 Hypothese der Fibroblasten-Abhängigkeit 3 1.2.1.2 Hypothese der T-Zell-Abhängigkeit 4 1.3 Allgemeine Anatomie und Histologie des Kniegelenks 6 1.4 Die Histopathologie der rheumatoiden Arthritis 9 1.4.1 Verschiedene Synovialmembrantypen bei rheumatoider Arthritis 10 1.5 Tiermodelle zur Untersuchung der rheumatoiden Arthritis 11 1.5.1 Das Tiermodell der Fibroblasten-induzierten Gelenkdestruktion in der BALB/c-Maus 12 1.6 Histopathologische Score-Systeme der rheumatoiden Arthritis in Tiermodellen 13 1.7 Ziel 13 1.7.1 Fragestellungen 14 2 Material und Methoden 16 2.1 Zelllinien und Versuchstiere 16 2.1.1 Die Fibroblasten-Zelllinie NIH/3T3 16 2.1.2 Die Fibroblasten-Zelllinie LS48 16 2.1.3 Die BALB/c-Maus 17 2.2 Tierversuchsplan 18 2.3 Zellkultur 19 2.3.1 Geräte und Verbrauchsmaterialien 19 2.3.2 Reagenzien 20 2.3.3 Durchführung 21 2.4 Isolation der murinen Kniegelenke 22 2.5 Histologische Aufarbeitung 23 2.5.1 Geräte und Verbrauchsmaterialien 23 2.5.2 Reagenzien 24 2.5.3 Entkalkung, Entwässerung, Einbettung und Schneiden der Präparate 26 2.5.4 Azanfärbung nach Heidenhain (Kernechtrubin-Anillinblau-Orange G-Färbung) 27 2.6 Klassifikation mit dem Durchlichtmikroskop für das Modell der Fibroblasten-induzierten Knorpeldestruktion (Balb/c-LS48) 29 2.7 Klassifikation mit dem Polarisationsmikroskop für das Modell der Fibroblasten-induzierten Knorpeldestruktion (Balb/c-LS48) 29 2.8 Statistik 30 3 Ergebnisse 31 3.1 Score-Erhebung mit dem Lichtmikroskop für das Modell der Fibroblasten-induzierten Knorpeldestruktion (BALB/c-LS48) 31 3.1.1 Bewertungsmodus für den Score-Parameter Zellinvasion 32 3.1.2 Bewertungsmodus für den Score-Parameter Pannusformation 35 3.1.3 Bewertungsmodus für den Score-Parameter Knorpeldestruktion 38 3.2 Datenanalyse der lichtmikroskopisch untersuchten Parameter Zellinvasion, Pannusformation und Knorpeldestruktion für das Modell der Fibroblasten-induzierten Knorpeldestruktion (BALB/c-LS48) 41 3.2.1 Zellinvasion 41 3.2.2 Pannusformation 45 3.2.3 Knorpeldestruktion 48 3.2.4 Gesamtscore 51 3.3 Score-Erhebung mit dem Polarisationsmikroskop für das Modell der Fibroblasten-induzierten Knorpeldestruktion (BALB/c-LS48) 56 3.3.1 Bewertungsmodus für den Score-Parameter Knorpeldestruktion 56 3.4 Datenanalyse des polarisationsmikroskopisch untersuchten Parameters Knorpel-destruktion für das Modell der Fibroblasten-induzierten Knorpeldestruktion (BALB/c-LS48) 59 3.5 Statistischer Vergleich der licht- und polarisationsmikroskopischen Analysemethoden für den Parameter Knorpeldestruktion 62 3.6 Statistischer Vergleich der medialen und lateralen histologischen Sagittalschnitte der Kniegelenke 63 4 Diskussion 64 4.1 Die Bedeutung der histopathologischen Score-Parameter für das Modell der Fibroblasten-induzierten Gelenkdestruktion in der BALB/c-Maus 65 4.1.1 Der Score-Parameter Zellinvasion 65 4.1.1.1 Die pathophysiologische Bedeutung des Score-Parameters Zellinvasion 67 4.1.1.2 Interpretation der lichtmikroskopischen Befunde des Score-Parameters Zellinvasion für die Zelllinie LS48 im ipsilateralen Kniegelenk im Verlauf von zehn Wochen 69 4.1.2 Der Score-Parameter Pannusformation 70 4.1.2.1 Die pathophysiologische Bedeutung des Score-Parameters Pannusformation 71 4.1.2.2 Interpretation der lichtmikroskopischen Befunde des Score-Parameters Pannusformation für die Zelllinie LS48 im ipsilateralen Kniegelenk im Verlauf von zehn Wochen 73 4.1.3 Der Score-Parameter Knorpeldestruktion 74 4.1.3.1 Die pathophysiologische Bedeutung des Score-Parameters Knorpeldestruktion 75 4.1.3.2 Interpretation der lichtmikroskopischen Befunde des Score-Parameters Knorpeldestruktion für die Zelllinie LS48 im ipsilateralen Kniegelenk im Verlauf von zehn Wochen 76 4.1.4 Interpretation des lichtmikroskopisch erhobenen Gesamtscores für das Knorpeldestruktionsmodell (BALB/c-LS48) im ipsilateralen Kniegelenk im Verlauf von zehn Wochen 78 4.1.4.1 Verlaufsvergleich zu anderen Tiermodellen 81 4.2 Die histopathologischen Auswirkungen der Zelllinien LS48 und NIH/3T3 im ipsilateralen Kniegelenk der BALB/c-Maus im Vergleich 83 4.3 Vergleich der medialen und lateralen Sagittalebenen der histologischen Präparate der Kniegelenke 85 4.4 Beurteilung histopathologischer Veränderungen in den kontralateralen Kniegelenken im Verlauf von zehn Wochen 86 4.5 Vergleich der licht- und polarisationsmikroskopischen Untersuchungsergebnisse 87 4.6 Schlussfolgerungen und Ausblick 89 Zusammenfassung 94 Literaturverzeichnis 99 Abbildungs- und Tabellenverzeichnis 116 Eigenständigkeitserklärung VIII Danksagung IX